Comments
Drug firm Ajanta Pharma today reported a 40.88 per cent increase in its standalone net profit to Rs 78.63 crore for the quarter ended September 30, 2014, mainly on account of robust exports.
The company had posted a net profit of Rs 55.81 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a filing to BSE.
Standalone total income of the company also rose to Rs 337.30 crore for the quarter under consideration from Rs 279.83 crore for the same period year ago.
“Our business performance remained aligned to all our plans in all the markets we operate in...,” Ajanta Pharma Managing Director Yogesh M Agrawal said.
Exports contributed 64 per cent of the revenue for the quarter, the company said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.